This is a preview of subscription content, log in via an institution to check access.
Notes
see PharmacoEconomics & Outcomes News 675 p2; 803085438
Reference
Jain A. The Novartis case: weighing innovation against access. BMJ : 8 Apr 2013. Available from: URL: http://dx.doi.org/10.1136/bmj.f2218
Rights and permissions
About this article
Cite this article
Indian Novartis case: innovation vs access. PharmacoEcon Outcomes News 676, 4 (2013). https://doi.org/10.1007/s40274-013-0311-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0311-z